US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Corcept Therapeutics

71.71

-0.0800-0.11%

Pre-market: 71.21-0.5000-0.70%05:28 EDT

Volume:1.28M

Turnover:91.20M

Market Cap:7.57B

PE:58.30

High:73.16

Open:72.35

Low:69.56

Close:71.79

Loading ...

Overview Company News Filings

Piper Sandler Reaffirms Their Buy Rating on Corcept Therapeutics (CORT)

3 Growth Companies With High Insider Ownership Achieving 70% Earnings Growth

Simply Wall St.

Is Corcept Therapeutics Incorporated (CORT) Among the Best Guru Stocks to Buy According to Wall Street Analysts?

CORCEPT TO PRESENT LATE-BREAKING DATA FROM PIVOTAL PHASE 3 ROSELLA TRIAL OF RELACORILANT IN PLATINUM-RESISTANT OVARIAN CANCER AT ASCO 2025

BRIEF-Diabetes Care Publishes Results From Prevalence Phase Of Corcept’S CATALYST Trial In People With Difficult-To-Control Type 2 Diabetes

Diabetes Care Publishes Results From Prevalence Phase of Corcept’s Catalyst Trial in People With Difficult-to-Control Type 2 Diabetes

THOMSON REUTERS

Analysts’ Top Healthcare Picks: Merus (MRUS), Corcept Therapeutics (CORT)

Corcept Therapeutics (NasdaqCM:CORT) Rises 36% in Last Quarter

Simply Wall St.

BRIEF-Corcept Initiates Trial Of Relacorilant Plus NAB-Paclitaxel And Bevacizumab

Corcept Therapeutics Inc - Bella Trial to Enroll 90 Women With Platinum-Resistant Ovarian Cancer

THOMSON REUTERS

Corcept Initiates Trial of Relacorilant Plus Nab-Paclitaxel and Bevacizumab in Patients With Platinum-Resistant Ovarian Cancer

Corcept Therapeutics Is Maintained at Overweight by Piper Sandler

Form 4 | CORCEPT THERAPEUTICS INC Officer Joseph Douglas Lyon sold 200,650 Shares.

Biotech Stock Roundup: CORT Up on Study Data, Updates From AXSM, BMY, EXEL & More

Does Corcept (CORT) Have the Potential to Rally 28.63% as Wall Street Analysts Expect?

APLS' Empaveli sNDA for 2 Rare Kidney Diseases Gets FDA Priority Tag

CORT Shares Rise as Relacorilant Combo Meets Ovarian Cancer Study Goal

Corcept Therapeutics Is Maintained at Buy by Canaccord Genuity

SNY Gets FDA Nod for First Ever Hemophilia Drug in the United States

AstraZeneca's Imfinzi Gets FDA Nod for Bladder Cancer Indication

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CORT/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CORT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CORT\",,,,,undefined,":{"symbol":"CORT","market":"US","secType":"STK","nameCN":"Corcept Therapeutics","latestPrice":71.71,"timestamp":1745611200000,"preClose":71.79,"halted":0,"volume":1279548,"hourTrading":{"tag":"盘前","latestPrice":71.21,"preClose":71.71,"latestTime":"05:28 EDT","volume":23,"amount":1632.4500699999999,"timestamp":1745832509240},"delay":0,"floatShares":86953354,"shares":105503432,"eps":1.23,"marketStatus":"Pre-Mkt","change":-0.08,"latestTime":"04-28 05:31:07 EDT","open":72.35,"high":73.16,"low":69.56,"amount":91196955.89892,"amplitude":0.050146,"askPrice":103.12,"askSize":100,"bidPrice":65,"bidSize":8,"shortable":3,"etf":0,"ttmEps":1.23,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1745847000000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1081915200000,"exchange":"NASDAQ","adjPreClose":71.71,"preHourTrading":{"tag":"盘前","latestPrice":71.21,"preClose":71.71,"latestTime":"05:28 EDT","volume":23,"amount":1632.4500699999999,"timestamp":1745832509240},"postHourTrading":{"tag":"盘后","latestPrice":71.25,"preClose":71.71,"latestTime":"19:59 EDT","volume":91842,"amount":6584872.6389,"timestamp":1745625588237},"volumeRatio":0.778039059753914,"impliedVol":0.7675,"impliedVolPercentile":0.7189},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CORT\",,,,,undefined,":{"symbol":"CORT","floatShares":86953354,"roa":"11.71%","roe":"23.81%","lyrEps":1.353582,"volumeRatio":0.778039059753914,"shares":105503432,"dividePrice":0,"high":73.16,"amplitude":0.050146,"preClose":71.79,"low":69.56,"week52Low":22.28,"pbRate":"11.13","psRate":"11.21","week52High":117.33,"institutionHeld":0.7266,"latestPrice":71.71,"committee":-0.851852,"eps":1.23,"divideRate":0,"volume":1279548,"delay":0,"ttmEps":1.23,"open":72.35,"prevYearClose":50.39,"prevWeekClose":71.71,"prevMonthClose":114.22,"prevQuarterClose":114.22,"fiveDayClose":62.24,"twentyDayClose":56.68,"sixtyDayClose":61.53},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CORT\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2530878188","title":"Piper Sandler Reaffirms Their Buy Rating on Corcept Therapeutics (CORT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2530878188","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530878188?lang=en_us&edition=fundamental","pubTime":"2025-04-25 18:34","pubTimestamp":1745577268,"startTime":"0","endTime":"0","summary":"Piper Sandler analyst David Amsellem reiterated a Buy rating on Corcept Therapeutics (CORT – Research Report) today and set a price target of $131....","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/piper-sandler-reaffirms-their-buy-rating-on-corcept-therapeutics-cort-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/piper-sandler-reaffirms-their-buy-rating-on-corcept-therapeutics-cort-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CORT"],"gpt_icon":0},{"id":"2529986633","title":"3 Growth Companies With High Insider Ownership Achieving 70% Earnings Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2529986633","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529986633?lang=en_us&edition=fundamental","pubTime":"2025-04-24 19:35","pubTimestamp":1745494528,"startTime":"0","endTime":"0","summary":"Over the last 7 days, the United States market has risen by 2.3%, contributing to a 5.9% increase over the past year, with earnings forecasted to grow by 14% annually. In this environment of steady growth, companies that combine robust earnings potential with significant insider ownership often stand out as promising opportunities for investors seeking alignment between management and shareholder interests.Top 10 Growth Companies With High Insider Ownership In The United States. Click here to see the full list of 204 stocks from our Fast Growing US Companies With High Insider Ownership screener.Corcept Therapeutics is experiencing strong growth, with earnings expected to increase significantly at 39% annually, outpacing the US market. Recent trials like ROSELLA and BELLA highlight its focus on relacorilant for treating serious conditions such as platinum-resistant ovarian cancer and hypercortisolism. The company's revenue is forecasted to grow at 24.8% per year, surpassing the market a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/3-growth-companies-high-insider-113528271.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SMCI","CRWV","CORT"],"gpt_icon":1},{"id":"2529565826","title":"Is Corcept Therapeutics Incorporated (CORT) Among the Best Guru Stocks to Buy According to Wall Street Analysts?","url":"https://stock-news.laohu8.com/highlight/detail?id=2529565826","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529565826?lang=en_us&edition=fundamental","pubTime":"2025-04-24 00:55","pubTimestamp":1745427315,"startTime":"0","endTime":"0","summary":"We recently published a list of 11 Best Guru Stocks to Buy According to Wall Street Analysts. In this article, we are going to take a look at where Corcept Therapeutics Incorporated  stands against other Guru stocks to invest in.The market uncertainty is reflected in ETFs as well, which are often considered wiser investment options due to active management strategies and lower risk compared to individual investing. For example, the Guru ETF is down 8.30% year-to-date as of April 18. However, over the last 12 months, the fund has posted share price returns of 13.38%. Similarly, five-year share returns stand at an impressive 51.57%. GURU gives retail investors a way to tap into the top stock picks of major hedge funds at a relatively low 0.75%","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/corcept-therapeutics-incorporated-cort-among-165515574.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PSQ","USAW.SI","TQQQ","BK4532","USJW.SI","LU0566484027.USD","QID","QLD","BK4007","CORT","NVIW.SI","PROC","SQQQ","NQmain","LU1559883803.SGD","MNQmain","TSYW.SI",".IXIC"],"gpt_icon":1},{"id":"2529637069","title":"CORCEPT TO PRESENT LATE-BREAKING DATA FROM PIVOTAL PHASE 3 ROSELLA TRIAL OF RELACORILANT IN PLATINUM-RESISTANT OVARIAN CANCER AT ASCO 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2529637069","media":"Business Wire","labels":["conferences","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529637069?lang=en_us&edition=fundamental","pubTime":"2025-04-23 23:30","pubTimestamp":1745422200,"startTime":"0","endTime":"0","summary":"REDWOOD CITY, Calif., April 23, 2025----Corcept Therapeutics Incorporated , a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, will present data from its pivotal Phase 3 ROSELLA trial of relacorilant plus nab-paclitaxel in patients with platinum-resistant ovarian cancer at the 2025 American Society of Clinical Oncology  Annual Meeting. The data will be presented in a late-breaking oral presentation on Monday, June 2, 2025.Title: ROSELLA: A Phase 3 Study of Relacorilant in Combination with Nab-Paclitaxel versus Nab-Paclitaxel Monotherapy in Patients with Platinum-Resistant Ovarian Cancer . The ROSELLA trial is being conducted in collaboration with The GOG Foundation, Inc. , the European Network of Gynaecological Oncological Trial groups , the Asia-Pacific Gynecologic Oncology Trials Group , the Latin American Cooperative Oncolog","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/corcept-present-breaking-data-pivotal-153000513.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CORT","BK4201","BK4532","LU1559883803.SGD","BK4007","LU0566484027.USD","EC"],"gpt_icon":0},{"id":"2529034158","title":"BRIEF-Diabetes Care Publishes Results From Prevalence Phase Of Corcept’S CATALYST Trial In People With Difficult-To-Control Type 2 Diabetes","url":"https://stock-news.laohu8.com/highlight/detail?id=2529034158","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529034158?lang=en_us&edition=fundamental","pubTime":"2025-04-21 20:17","pubTimestamp":1745237829,"startTime":"0","endTime":"0","summary":"BRIEF-Diabetes Care Publishes Results From Prevalence Phase Of Corcept’S CATALYST Trial In People With Difficult-To-Control Type 2 DiabetesApril 21 (Reuters) - Corcept Therapeutics Inc CORT.O:DIABETES","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250421:nTUA8TTPSX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LU1559883803.SGD","LU0566484027.USD","CORT","BK4532"],"gpt_icon":1},{"id":"2529651808","title":"Diabetes Care Publishes Results From Prevalence Phase of Corcept’s Catalyst Trial in People With Difficult-to-Control Type 2 Diabetes","url":"https://stock-news.laohu8.com/highlight/detail?id=2529651808","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529651808?lang=en_us&edition=fundamental","pubTime":"2025-04-21 20:00","pubTimestamp":1745236803,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250421:nTUA8TTPSX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","CORT","LU0566484027.USD","BK4532","LU1559883803.SGD"],"gpt_icon":0},{"id":"2528719732","title":"Analysts’ Top Healthcare Picks: Merus (MRUS), Corcept Therapeutics (CORT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2528719732","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528719732?lang=en_us&edition=fundamental","pubTime":"2025-04-17 20:13","pubTimestamp":1744892010,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Merus (MRUS – Research Report) and Corcept Therapeut...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-merus-mrus-corcept-therapeutics-cort?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-merus-mrus-corcept-therapeutics-cort?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0320765992.SGD","BK4007","LU1559883803.SGD","BK4137","HCSG","LU0889565916.HKD","BK4532","LU0566484027.USD","MRUS","CORT","LU0109394709.USD","BK4139"],"gpt_icon":0},{"id":"2526317979","title":"Corcept Therapeutics (NasdaqCM:CORT) Rises 36% in Last Quarter","url":"https://stock-news.laohu8.com/highlight/detail?id=2526317979","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526317979?lang=en_us&edition=fundamental","pubTime":"2025-04-10 03:02","pubTimestamp":1744225337,"startTime":"0","endTime":"0","summary":"Corcept Therapeutics saw a remarkable 36% increase in its share price in the last quarter, driven by several key developments. The company's significant announcement on March 31, detailing the successful Phase 3 trial results of the ROSELLA study, likely provided a strong boost to investor confidence, as it highlighted a 30% reduction in disease progression risk for its treatment in ovarian cancer. This positive momentum was further supported by the initiation of the BELLA and MOMENTUM trials, showcasing Corcept's continuous efforts in advancing its pipeline. These developments, against a backdrop of a challenging market environment that saw a 12% decline, underscore their potential significance for Corcept’s growth.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/corcept-therapeutics-nasdaqcm-cort-rises-190217885.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1559883803.SGD","BK4007","CORT","BK4532","LU0566484027.USD"],"gpt_icon":0},{"id":"2525304875","title":"BRIEF-Corcept Initiates Trial Of Relacorilant Plus NAB-Paclitaxel And Bevacizumab","url":"https://stock-news.laohu8.com/highlight/detail?id=2525304875","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525304875?lang=en_us&edition=fundamental","pubTime":"2025-04-07 20:54","pubTimestamp":1744030446,"startTime":"0","endTime":"0","summary":"BRIEF-Corcept Initiates Trial Of Relacorilant Plus NAB-Paclitaxel And BevacizumabApril 7 (Reuters) - Corcept Therapeutics Inc CORT.O:CORCEPT INITIATES TRIAL OF RELACORILANT PLUS NAB-PACLITAXEL AND BEV","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250407:nTUA9TPGFQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0566484027.USD","CORT","LU1559883803.SGD","BK4007","BK4532"],"gpt_icon":0},{"id":"2525012030","title":"Corcept Therapeutics Inc - Bella Trial to Enroll 90 Women With Platinum-Resistant Ovarian Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2525012030","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525012030?lang=en_us&edition=fundamental","pubTime":"2025-04-07 20:00","pubTimestamp":1744027203,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250407:nTUA9TPGFQ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4532","LU1559883803.SGD","LU0566484027.USD","BK4007","CORT"],"gpt_icon":0},{"id":"2525704880","title":"Corcept Initiates Trial of Relacorilant Plus Nab-Paclitaxel and Bevacizumab in Patients With Platinum-Resistant Ovarian Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2525704880","media":"Business Wire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525704880?lang=en_us&edition=fundamental","pubTime":"2025-04-07 20:00","pubTimestamp":1744027200,"startTime":"0","endTime":"0","summary":"REDWOOD CITY, Calif., April 07, 2025----Corcept Therapeutics Incorporated , a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced the start of BELLA, a Phase 2 trial of relacorilant plus nab-paclitaxel and bevacizumab evaluating efficacy and safety in patients with platinum-resistant ovarian cancer.BELLA is a single-arm, open-label trial with a planned enrollment of 90 women with recurrent, platinum-resistant ovarian cancer at approximately 50 sites in North America, Europe and Asia-Pacific. Patients will receive relacorilant in combination with nab-paclitaxel and bevacizumab.\"In our pivotal Phase 3 ROSELLA trial, treatment with relacorilant and nab-paclitaxel improved patients’ progression-free and overall survival, without increasing their side effect burden,\" said Bill Guyer, PharmD, Corcept’s Chief Development ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/corcept-initiates-trial-relacorilant-plus-120000565.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0566484027.USD","BK4532","CORT","BK4201","BK4007","LU1559883803.SGD","EC"],"gpt_icon":0},{"id":"2524684252","title":"Corcept Therapeutics Is Maintained at Overweight by Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2524684252","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524684252?lang=en_us&edition=fundamental","pubTime":"2025-04-03 21:04","pubTimestamp":1743685440,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CORT/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 03, 2025 09:04 ET (13:04 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":"47103062d186ffca036e42216ddd23e9","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CORT"],"gpt_icon":0},{"id":"1180105685","title":"Form 4 | CORCEPT THERAPEUTICS INC Officer Joseph Douglas Lyon sold 200,650 Shares.","url":"https://stock-news.laohu8.com/highlight/detail?id=1180105685","media":"Filings Track","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1180105685?lang=en_us&edition=fundamental","pubTime":"2025-04-03 08:20","pubTimestamp":1743639626,"startTime":"0","endTime":"0","summary":"CORCEPT THERAPEUTICS INC's Officer Joseph Douglas Lyon conducted multiple transactions on March 31 and April 1, selling a total of 200,650 shares of common stock, including several instances of shares acquired through option exercises before sale. Intensive reduction by executives typically implies the current stock price may be overvalued, which is worth investors' attention.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Form 4 | CORCEPT THERAPEUTICS INC Officer Joseph Douglas Lyon sold 200,650 Shares.","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CORT"],"gpt_icon":0},{"id":"2524449342","title":"Biotech Stock Roundup: CORT Up on Study Data, Updates From AXSM, BMY, EXEL & More","url":"https://stock-news.laohu8.com/highlight/detail?id=2524449342","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524449342?lang=en_us&edition=fundamental","pubTime":"2025-04-03 03:00","pubTimestamp":1743620400,"startTime":"0","endTime":"0","summary":"It was a busy week in the biotech sector, marked by significant regulatory and pipeline updates. Among these, shares of Corcept Therapeutics Incorporated CORT skyrocketed after a late-stage study met its primary goal. On the other hand, Axsome Therapeutics’ AXSM shares declined after announcing results from a study on major depressive disorder .Shares of Corcept Therapeutics Incorporated surged on March 31 after the company announced the success of the late-stage ROSELLA study.The phase III ROSELLA study evaluated its pipeline candidate, relacorilant, in combination with nab-paclitaxel for treating patients with platinum-resistant ovarian cancer.Axsome Therapeutics announced top-line data from the phase III PARADIGM study, which evaluated solriamfetol for the treatment of major depressive disorder  with and without severe excessive daytime sleepiness .Nonetheless, in the prespecified subgroup of patients with severe EDS, treatment with solriamfetol led to greater improvements in depres","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/biotech-stock-roundup-cort-study-190000499.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1323610961.USD","LU0306806265.USD","LU1571399168.USD","LU1670711040.USD","OS","LU1670710661.SGD","LU2360032135.SGD","BLUE","BMY","LU0321505868.SGD","LU1291159041.SGD","BK4556","LU1989771016.USD","LU0321505439.SGD","PFS","BK4505","LU0096364046.USD","LU2125154935.USD","AXSM","LU1093756168.USD","LU1670710588.SGD","BK4578","LU0566484027.USD","LU0882574055.USD","LU0456855351.SGD","LU2125154778.USD","CORT","EXEL","LU2242652126.USD","LU0306807586.USD","LU0985481810.HKD","LU1718418525.SGD","BK4585","LU1074936037.SGD","IE00BSNM7G36.USD","BK4532","IE00BJJMRZ35.SGD","LU1585245621.USD","LU1670711123.USD","LU2242646821.SGD","BK4534","LU1868836757.USD","LU1868836591.USD","BK4007","IE00B2B36J28.USD","BK4097","IE00BJT1NW94.SGD","LU1093756325.SGD","LU0225284248.USD","BK4588"],"gpt_icon":1},{"id":"2524109415","title":"Does Corcept (CORT) Have the Potential to Rally 28.63% as Wall Street Analysts Expect?","url":"https://stock-news.laohu8.com/highlight/detail?id=2524109415","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524109415?lang=en_us&edition=fundamental","pubTime":"2025-04-02 21:55","pubTimestamp":1743602109,"startTime":"0","endTime":"0","summary":"Corcept Therapeutics  closed the last trading session at $91.93, gaining 64.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $118.25 indicates a 28.6% upside potential.The average comprises four short-term price targets ranging from a low of $78 to a high of $150, with a standard deviation of $30.42. While the lowest estimate indicates a decline of 15.2% from the current price level, the most optimistic estimate points to a 63.2% upside. More than the range, one should note the standard deviation here, as it helps understand the variability of the estimates. The smaller the standard deviation, the greater the agreement among analysts.However, an impressive consensus price target is not the only factor that indicates a potential upside in CORT. This view is strengthened by the agreement among analysts that the company will report better earnings than what the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/does-corcept-cort-potential-rally-135509890.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","LU1559883803.SGD","BK4532","CORT","LU0566484027.USD"],"gpt_icon":0},{"id":"2524581497","title":"APLS' Empaveli sNDA for 2 Rare Kidney Diseases Gets FDA Priority Tag","url":"https://stock-news.laohu8.com/highlight/detail?id=2524581497","media":"Zacks","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524581497?lang=en_us&edition=fundamental","pubTime":"2025-04-02 21:11","pubTimestamp":1743599460,"startTime":"0","endTime":"0","summary":"A filing accepted under the regulatory body’s Priority Review pathway reduces the review period to six months from the standard 10 months. This status is awarded to marketing applications for medicines intended to treat serious conditions and that, if approved, would offer a substantial improvement in safety, effectiveness, prevention, or diagnosis of such conditions.A final decision from the FDA is expected on July 28, 2025.Please note that Empaveli is approved in the United States for the treatment of paroxysmal nocturnal hemoglobinuria . The drug is also approved in Europe under the brand name Aspaveli for the same indication.Year to date, shares of Apellis have plunged 28.9% against theindustry’s 2.4% growth.In the VALIANT study, Empaveli was overall well-tolerated with a consistent safety profile. Adverse events were mostly mild to moderate in severity.Novartis recently announced that the FDA has approved Fabhalta for a third indication, C3G, to reduce proteinuria.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/apls-empaveli-snda-2-rare-131100793.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4505","BK4007","BK4578","IE00BJJMRZ35.SGD","APLS","BAYRY","IE00B2B36J28.USD","BK4588","IE00BFTCPJ56.SGD","CORT","LU0211331839.USD","BK4585","LU0070302665.USD","IE00BJT1NW94.SGD","LU0320765489.SGD","LU1559883803.SGD","BK4139","LU0208291251.USD","LU1093756325.SGD","IE0002141913.USD","IE0009355771.USD","LU1093756168.USD","LU0566484027.USD","BK4532","NVS","IE00B4R5TH58.HKD"],"gpt_icon":0},{"id":"2524128774","title":"CORT Shares Rise as Relacorilant Combo Meets Ovarian Cancer Study Goal","url":"https://stock-news.laohu8.com/highlight/detail?id=2524128774","media":"Zacks","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524128774?lang=en_us&edition=fundamental","pubTime":"2025-04-01 22:50","pubTimestamp":1743519000,"startTime":"0","endTime":"0","summary":"Shares of Corcept Therapeutics Incorporated CORT were up a staggering 109.1% on March 31 after the company announced data from the phase III ROSELLA study, which evaluated its pipeline candidate, relacorilant, in combination with nab-paclitaxel for treating patients with platinum-resistant ovarian cancer.The ROSELLA study met its primary endpoint of improved progression-free survival, as assessed by blinded independent central review .Per management, data from the ROSELLA study suggested that the combo of relacorilant plus nab-paclitaxel has the potential to become a new standard of care for patients with platinum-resistant ovarian cancer.Year to date, shares of Corcept have skyrocketed 126.7% against the industry’s decline of 1.9%.The phase III ROSELLA study evaluated relacorilant in combination with nab-paclitaxel for treating patients with recurrent, platinum-resistant ovarian cancer.Data from the same showed that treatment with relacorilant plus nab-paclitaxel reduced the risk of d","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cort-shares-rise-relacorilant-combo-145000011.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0566484027.USD","BK4007","FOLD","LU2065169927.USD","OS","CORT","LU2065171311.SGD","LU2065171402.SGD","ANIP","LU2065170008.USD","CTMX","LU1559883803.SGD","BK4139","BK4097","BK4532"],"gpt_icon":0},{"id":"2524811253","title":"Corcept Therapeutics Is Maintained at Buy by Canaccord Genuity","url":"https://stock-news.laohu8.com/highlight/detail?id=2524811253","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524811253?lang=en_us&edition=fundamental","pubTime":"2025-04-01 21:45","pubTimestamp":1743515100,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CORT/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 01, 2025 09:45 ET (13:45 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CORT"],"gpt_icon":0},{"id":"2524145956","title":"SNY Gets FDA Nod for First Ever Hemophilia Drug in the United States","url":"https://stock-news.laohu8.com/highlight/detail?id=2524145956","media":"Zacks","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524145956?lang=en_us&edition=fundamental","pubTime":"2025-04-01 21:44","pubTimestamp":1743515040,"startTime":"0","endTime":"0","summary":"SanofiSNY and partner,Alnylam Pharmaceuticals ALNY, announced that the FDA has approved Qfitlia  as the first antithrombin-lowering  therapy for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients  with hemophilia A or B with or without factor VIII or IX inhibitors in the United States.Hemophilia A and B are rare, lifelong congenital bleeding disorders that impair the blood's ability to clot, causing excessive bleeding and spontaneous joint bleeds. These can lead to joint damage, chronic pain, which takes a significant toll on the patients’ quality of life.This FDA approval is based on positive data from the phase III ATLAS studies of Qfitlia, which showed clinically significant bleed protection, as measured by annualized bleeding rates , in hemophilia patients with or without inhibitors.Year to date, SNY stock has gained 15% compared with the industry’s 3.4% growth.Further analysis in the open-label extension study, under the ATL","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/sny-gets-fda-nod-first-134400996.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","IE00BFXG1179.USD","LU1559883803.SGD","ABR","CORT","BK4211","UBCP","BK4110","SNY","LU0566484027.USD","BK4532","ALNY","BK4588","BAYRY","BK4585","BK4139","BK4548"],"gpt_icon":0},{"id":"2524917146","title":"AstraZeneca's Imfinzi Gets FDA Nod for Bladder Cancer Indication","url":"https://stock-news.laohu8.com/highlight/detail?id=2524917146","media":"Zacks","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524917146?lang=en_us&edition=fundamental","pubTime":"2025-04-01 21:31","pubTimestamp":1743514260,"startTime":"0","endTime":"0","summary":"AstraZenecaAZN announced that the FDA has approved its blockbuster drug, Imfinzi, for a bladder cancer indication in the United States.Imfinzi is approved in combination with gemcitabine and cisplatin as a neoadjuvant treatment for muscle-invasive bladder cancer , a type of bladder cancer that has spread into the muscle wall of the bladder. The regulatory filing for the drug was reviewed under the FDA’s Priority Review Pathway. This marks the first approval for Imfinzi for a bladder cancer indication.AstraZeneca’s Imfinzi, either as a monotherapy or in combination with chemotherapy, is presently approved for stage III non-small cell lung cancer, extensive-stage small cell lung cancer, locally advanced or metastatic biliary tract cancer and endometrial cancer that is mismatch repair deficient and in combination with Imjudo in unresectable hepatocellular carcinoma in some countries. The drug has also recently been approved for limited-stage small cell lung cancer in the United States and","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/astrazenecas-imfinzi-gets-fda-nod-133100339.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1559883803.SGD","CHMP","DVAX","LU2417539215.USD","BK4568","AZN","BK4139","CORT","LU0566484027.USD","LU0109394709.USD","BK4007","LU2236285917.USD","LU1829250122.USD","LU0889565916.HKD","LU2456880835.USD","BK4588","BK4585","LU0320765992.SGD","BK4532","LU2462157665.USD","BAYRY","BK4087"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CORT\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-02-26","symbol":"CORT","fiscalQuarterEnding":"2024/12","expectedEps":0.37,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1740546000000,"reportTimeType":"post","actualEps":0.26},{"market":"US","date":"2024-10-30","symbol":"CORT","fiscalQuarterEnding":"2024/09","expectedEps":0.27,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730260800000,"reportTimeType":"post","actualEps":0.41},{"market":"US","date":"2024-07-29","symbol":"CORT","fiscalQuarterEnding":"2024/06","expectedEps":0.23,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1722225600000,"reportTimeType":"post","actualEps":0.32},{"market":"US","date":"2024-05-01","symbol":"CORT","fiscalQuarterEnding":"2024/03","expectedEps":0.21,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1714536000000,"reportTimeType":"post","actualEps":0.25},{"market":"US","date":"2024-02-15","symbol":"CORT","fiscalQuarterEnding":"2023/12","expectedEps":0.25,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1707973200000,"reportTimeType":"post","actualEps":0.28}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CORT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CORT\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":4,"updateTime":1700107200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CORT\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CORT","date":"2025-04-25","current":53.637455,"percent":0.991877,"low":12.617742,"twenty":20.348792,"median":24.821915,"eighty":29.620251,"high":85.338767,"avg":26.337769,"sd":8.020301,"marketCap":7574091383},"quantilePoints":[{"date":"2020-05-01","current":14.845254,"twenty":-29.662778,"median":10.16729,"eighty":18.080162,"marketCap":1398140837},{"date":"2020-05-08","current":14.523657,"twenty":-29.662778,"median":10.246957,"eighty":18.080162,"marketCap":1539100938},{"date":"2020-05-15","current":15.20496,"twenty":-29.662778,"median":10.402606,"eighty":18.080162,"marketCap":1611300014},{"date":"2020-05-22","current":17.032583,"twenty":-29.662778,"median":10.509751,"eighty":18.080162,"marketCap":1804976901},{"date":"2020-05-29","current":16.372908,"twenty":-29.662778,"median":10.517599,"eighty":18.080162,"marketCap":1735069859},{"date":"2020-06-05","current":15.345546,"twenty":-29.662778,"median":10.570633,"eighty":18.080162,"marketCap":1626198236},{"date":"2020-06-12","current":15.788934,"twenty":-29.662778,"median":10.632312,"eighty":18.080162,"marketCap":1673184936},{"date":"2020-06-19","current":17.503007,"twenty":-29.662778,"median":10.674036,"eighty":18.080162,"marketCap":1854828643},{"date":"2020-06-26","current":18.005874,"twenty":-29.662778,"median":10.737672,"eighty":18.13832,"marketCap":1908118438},{"date":"2020-07-02","current":18.579034,"twenty":-29.662778,"median":10.816326,"eighty":18.1602,"marketCap":1968857343},{"date":"2020-07-10","current":17.838251,"twenty":-29.662778,"median":10.956625,"eighty":18.168521,"marketCap":1890355173},{"date":"2020-07-17","current":17.82203,"twenty":-29.662778,"median":11.143818,"eighty":18.168521,"marketCap":1888636147},{"date":"2020-07-24","current":17.421899,"twenty":-29.662778,"median":11.212718,"eighty":18.178004,"marketCap":1846233515},{"date":"2020-07-31","current":16.167436,"twenty":-29.662778,"median":11.288088,"eighty":18.178004,"marketCap":1713295534},{"date":"2020-08-07","current":14.116479,"twenty":-29.662778,"median":11.383285,"eighty":18.178004,"marketCap":1610873724},{"date":"2020-08-14","current":13.939263,"twenty":-29.662778,"median":11.447928,"eighty":18.178004,"marketCap":1590651134},{"date":"2020-08-21","current":13.078502,"twenty":-29.662778,"median":11.607146,"eighty":18.178004,"marketCap":1492427127},{"date":"2020-08-28","current":12.769641,"twenty":-29.662778,"median":11.77016,"eighty":18.178004,"marketCap":1457182042},{"date":"2020-09-04","current":20.232944,"twenty":-29.662778,"median":12.0681,"eighty":18.192931,"marketCap":2308841966},{"date":"2020-09-11","current":17.964586,"twenty":-29.662778,"median":12.313861,"eighty":18.22447,"marketCap":2049992817},{"date":"2020-09-18","current":18.217751,"twenty":-29.662778,"median":12.50872,"eighty":18.227697,"marketCap":2078882231},{"date":"2020-09-25","current":17.306357,"twenty":-29.662778,"median":12.690857,"eighty":18.227697,"marketCap":1974880341},{"date":"2020-10-02","current":17.134205,"twenty":-29.662778,"median":12.772759,"eighty":18.227697,"marketCap":1955235539},{"date":"2020-10-09","current":18.582309,"twenty":-29.662778,"median":12.948505,"eighty":18.242559,"marketCap":2120482987},{"date":"2020-10-16","current":18.227878,"twenty":-29.662778,"median":13.039541,"eighty":18.265281,"marketCap":2080037808},{"date":"2020-10-23","current":18.075979,"twenty":-29.662778,"median":13.12871,"eighty":18.265281,"marketCap":2062704159},{"date":"2020-10-30","current":16.992433,"twenty":-29.662778,"median":13.207771,"eighty":18.265281,"marketCap":1939057467},{"date":"2020-11-06","current":19.210299,"twenty":-29.662778,"median":13.384252,"eighty":18.317545,"marketCap":2101568249},{"date":"2020-11-13","current":19.210299,"twenty":-29.662778,"median":13.650021,"eighty":18.406303,"marketCap":2101568249},{"date":"2020-11-20","current":25.411965,"twenty":-29.662778,"median":13.746278,"eighty":18.477389,"marketCap":2780018143},{"date":"2020-11-27","current":24.413752,"twenty":-29.662778,"median":13.837384,"eighty":18.52368,"marketCap":2670815591},{"date":"2020-12-04","current":25.008432,"twenty":-29.662778,"median":13.946858,"eighty":18.566015,"marketCap":2735872430},{"date":"2020-12-11","current":26.888046,"twenty":-29.662778,"median":14.03291,"eighty":18.609219,"marketCap":2941498511},{"date":"2020-12-18","current":27.88626,"twenty":-29.662778,"median":14.128307,"eighty":18.66755,"marketCap":3050701063},{"date":"2020-12-24","current":28.873854,"twenty":-29.662778,"median":14.204207,"eighty":18.752824,"marketCap":3158741885},{"date":"2020-12-31","current":27.780067,"twenty":-29.662778,"median":14.259111,"eighty":18.823955,"marketCap":3039083770},{"date":"2021-01-08","current":28.852615,"twenty":-29.662778,"median":14.437044,"eighty":18.90799,"marketCap":3156418426},{"date":"2021-01-15","current":29.882687,"twenty":-29.662778,"median":14.544352,"eighty":19.043327,"marketCap":3269106165},{"date":"2021-01-22","current":29.797732,"twenty":-29.662778,"median":14.568513,"eighty":19.173242,"marketCap":3259812331},{"date":"2021-01-29","current":30.010118,"twenty":-29.662778,"median":14.642599,"eighty":19.220775,"marketCap":3283046917},{"date":"2021-02-05","current":31.231337,"twenty":-29.662778,"median":14.727532,"eighty":19.357645,"marketCap":3416645783},{"date":"2021-02-12","current":29.734017,"twenty":-29.662778,"median":14.762883,"eighty":19.474737,"marketCap":3252841956},{"date":"2021-02-19","current":28.608372,"twenty":-29.662778,"median":14.848087,"eighty":19.754982,"marketCap":3129698653},{"date":"2021-02-26","current":27.831125,"twenty":-29.662778,"median":14.9005,"eighty":19.989119,"marketCap":2950405376},{"date":"2021-03-05","current":27.167162,"twenty":-29.662778,"median":14.992635,"eighty":20.173345,"marketCap":2880017971},{"date":"2021-03-12","current":28.428692,"twenty":-29.662778,"median":15.028869,"eighty":20.32634,"marketCap":3013754040},{"date":"2021-03-19","current":28.351229,"twenty":-29.662778,"median":15.068378,"eighty":20.471695,"marketCap":3005542176},{"date":"2021-03-26","current":27.089699,"twenty":-29.662778,"median":15.130098,"eighty":20.550186,"marketCap":2871806107},{"date":"2021-04-01","current":27.034369,"twenty":-29.662778,"median":15.171294,"eighty":20.747868,"marketCap":2865940490},{"date":"2021-04-09","current":25.09781,"twenty":-29.662778,"median":15.211446,"eighty":20.923746,"marketCap":2660643893},{"date":"2021-04-16","current":25.191871,"twenty":-29.662778,"median":15.278755,"eighty":21.20428,"marketCap":2670615442},{"date":"2021-04-23","current":26.40353,"twenty":-29.662778,"median":15.369745,"eighty":21.53034,"marketCap":2799064608},{"date":"2021-04-30","current":25.072352,"twenty":-29.662778,"median":15.47411,"eighty":22.287951,"marketCap":2657945100},{"date":"2021-05-07","current":24.754882,"twenty":-29.662778,"median":15.518576,"eighty":24.294815,"marketCap":2460907601},{"date":"2021-05-14","current":24.9074,"twenty":-29.662778,"median":15.610839,"eighty":24.413752,"marketCap":2476069591},{"date":"2021-05-21","current":25.247633,"twenty":-29.662778,"median":15.638633,"eighty":24.698476,"marketCap":2509892491},{"date":"2021-05-28","current":25.341491,"twenty":-29.662778,"median":15.686181,"eighty":24.861995,"marketCap":2519222947},{"date":"2021-06-04","current":25.11858,"twenty":-29.564231,"median":15.705567,"eighty":24.993109,"marketCap":2497063115},{"date":"2021-06-11","current":25.259366,"twenty":-29.564231,"median":15.782208,"eighty":25.114426,"marketCap":2511058798},{"date":"2021-06-18","current":26.397386,"twenty":-29.564231,"median":15.836865,"eighty":25.18427,"marketCap":2624190570},{"date":"2021-06-25","current":26.678958,"twenty":-29.564231,"median":15.876709,"eighty":25.257019,"marketCap":2652181936},{"date":"2021-07-02","current":26.174475,"twenty":-29.564231,"median":15.929368,"eighty":25.341445,"marketCap":2602030738},{"date":"2021-07-09","current":25.857706,"twenty":-29.357281,"median":15.951149,"eighty":25.408891,"marketCap":2570540451},{"date":"2021-07-16","current":23.698987,"twenty":-28.953237,"median":15.97248,"eighty":25.421286,"marketCap":2355939978},{"date":"2021-07-23","current":23.804576,"twenty":-28.83498,"median":16.047822,"eighty":25.421286,"marketCap":2366436740},{"date":"2021-07-30","current":24.668273,"twenty":7.658953,"median":16.153301,"eighty":25.421286,"marketCap":2407796084},{"date":"2021-08-06","current":25.927222,"twenty":8.529565,"median":16.182777,"eighty":25.604292,"marketCap":2530678311},{"date":"2021-08-13","current":24.561381,"twenty":8.686335,"median":16.258487,"eighty":25.617005,"marketCap":2397362687},{"date":"2021-08-20","current":24.466366,"twenty":8.870861,"median":16.364258,"eighty":25.617005,"marketCap":2388088557},{"date":"2021-08-27","current":25.570915,"twenty":9.046769,"median":16.394537,"eighty":25.617005,"marketCap":2495900322},{"date":"2021-09-03","current":25.570915,"twenty":9.231188,"median":16.443465,"eighty":25.64695,"marketCap":2495900322},{"date":"2021-09-10","current":25.06021,"twenty":9.353202,"median":16.481052,"eighty":25.64695,"marketCap":2446051871},{"date":"2021-09-17","current":24.359474,"twenty":9.563882,"median":16.545079,"eighty":25.64695,"marketCap":2377655160},{"date":"2021-09-24","current":24.098183,"twenty":9.648271,"median":16.60001,"eighty":25.64695,"marketCap":2352151302},{"date":"2021-10-01","current":23.563723,"twenty":9.818742,"median":16.632453,"eighty":25.64695,"marketCap":2299984319},{"date":"2021-10-08","current":24.157567,"twenty":9.8781,"median":16.710363,"eighty":25.642787,"marketCap":2357947633},{"date":"2021-10-15","current":23.801261,"twenty":9.911585,"median":16.806324,"eighty":25.642787,"marketCap":2323169645},{"date":"2021-10-22","current":22.233513,"twenty":10.120373,"median":16.916725,"eighty":25.642787,"marketCap":2170146494},{"date":"2021-10-29","current":21.378378,"twenty":10.16729,"median":16.975967,"eighty":25.638625,"marketCap":2086679322},{"date":"2021-11-05","current":22.428163,"twenty":10.247766,"median":17.021769,"eighty":25.638625,"marketCap":2387545188},{"date":"2021-11-12","current":24.946122,"twenty":10.405229,"median":17.108284,"eighty":25.638625,"marketCap":2655589545},{"date":"2021-11-19","current":24.805122,"twenty":10.509751,"median":17.160274,"eighty":25.638625,"marketCap":2640579691},{"date":"2021-11-26","current":23.308355,"twenty":10.517646,"median":17.193019,"eighty":25.638625,"marketCap":2481244318},{"date":"2021-12-03","current":22.679279,"twenty":10.570633,"median":17.245845,"eighty":25.638625,"marketCap":2414277277},{"date":"2021-12-10","current":20.336513,"twenty":10.633993,"median":17.285339,"eighty":25.638625,"marketCap":2164882781},{"date":"2021-12-17","current":20.45582,"twenty":10.674216,"median":17.377243,"eighty":25.638625,"marketCap":2177583426},{"date":"2021-12-23","current":19.753147,"twenty":10.722066,"median":17.416987,"eighty":25.638625,"marketCap":2102781801},{"date":"2021-12-31","current":19.703391,"twenty":10.819468,"median":17.454342,"eighty":25.638625,"marketCap":2097485121},{"date":"2022-01-07","current":18.857539,"twenty":10.913816,"median":17.567549,"eighty":25.634462,"marketCap":2007441568},{"date":"2022-01-14","current":18.359978,"twenty":11.137655,"median":17.627876,"eighty":25.634462,"marketCap":1954474772},{"date":"2022-01-21","current":17.106126,"twenty":11.176492,"median":17.634297,"eighty":25.634462,"marketCap":1820998446},{"date":"2022-01-28","current":17.524077,"twenty":11.270479,"median":17.649,"eighty":25.634462,"marketCap":1865490555},{"date":"2022-02-04","current":19.315294,"twenty":11.365143,"median":17.759255,"eighty":25.634462,"marketCap":2056171020},{"date":"2022-02-11","current":19.892464,"twenty":11.408008,"median":17.831672,"eighty":25.634462,"marketCap":2117612504},{"date":"2022-02-18","current":21.227889,"twenty":11.568834,"median":17.864938,"eighty":25.634462,"marketCap":2388392248},{"date":"2022-02-25","current":21.331486,"twenty":11.631674,"median":17.906314,"eighty":25.634462,"marketCap":2400048110},{"date":"2022-03-04","current":22.292109,"twenty":11.795058,"median":17.930398,"eighty":25.634462,"marketCap":2508129747},{"date":"2022-03-11","current":22.904271,"twenty":12.28719,"median":17.972454,"eighty":25.634462,"marketCap":2577005300},{"date":"2022-03-18","current":23.516432,"twenty":12.475052,"median":18.005093,"eighty":25.634462,"marketCap":2645880853},{"date":"2022-03-25","current":22.574645,"twenty":12.627441,"median":18.031905,"eighty":25.634462,"marketCap":2539918464},{"date":"2022-04-01","current":22.273273,"twenty":12.74917,"median":18.063294,"eighty":25.634462,"marketCap":2506010499},{"date":"2022-04-08","current":23.412836,"twenty":12.847907,"median":18.095067,"eighty":25.634462,"marketCap":2634224990},{"date":"2022-04-14","current":23.064375,"twenty":13.008366,"median":18.12447,"eighty":25.634462,"marketCap":2595018906},{"date":"2022-04-22","current":21.020696,"twenty":13.07616,"median":18.16833,"eighty":25.634462,"marketCap":2365080522},{"date":"2022-04-29","current":20.312779,"twenty":13.138468,"median":18.203209,"eighty":25.634462,"marketCap":2285431391},{"date":"2022-05-06","current":18.239814,"twenty":13.303116,"median":18.227652,"eighty":25.634462,"marketCap":2040013747},{"date":"2022-05-13","current":17.992816,"twenty":13.407715,"median":18.227652,"eighty":25.634462,"marketCap":2012388561},{"date":"2022-05-20","current":19.398802,"twenty":13.706817,"median":18.242251,"eighty":25.634462,"marketCap":2169639620},{"date":"2022-05-27","current":19.949796,"twenty":13.79308,"median":18.271684,"eighty":25.634462,"marketCap":2231265036},{"date":"2022-06-03","current":20.291793,"twenty":13.889642,"median":18.339285,"eighty":25.634462,"marketCap":2269515293},{"date":"2022-06-10","current":20.339292,"twenty":13.973328,"median":18.40556,"eighty":25.634462,"marketCap":2274827829},{"date":"2022-06-17","current":19.664799,"twenty":14.068138,"median":18.465203,"eighty":25.634462,"marketCap":2199389821},{"date":"2022-06-24","current":22.609769,"twenty":14.163827,"median":18.496311,"eighty":25.638625,"marketCap":2528767040},{"date":"2022-07-01","current":24.167753,"twenty":14.242503,"median":18.547204,"eighty":25.638625,"marketCap":2703018215},{"date":"2022-07-08","current":26.257732,"twenty":14.375881,"median":18.575405,"eighty":25.689659,"marketCap":2936769790},{"date":"2022-07-15","current":25.877736,"twenty":14.535395,"median":18.611477,"eighty":25.706312,"marketCap":2894269503},{"date":"2022-07-22","current":25.564239,"twenty":14.560417,"median":18.668127,"eighty":25.758082,"marketCap":2859206767},{"date":"2022-07-29","current":27.226722,"twenty":14.617956,"median":18.734208,"eighty":25.807402,"marketCap":3045145520},{"date":"2022-08-05","current":27.267222,"twenty":14.673898,"median":18.765235,"eighty":25.816914,"marketCap":3073915738},{"date":"2022-08-12","current":26.9917,"twenty":14.673898,"median":18.765235,"eighty":25.816914,"marketCap":3042855265},{"date":"2022-08-19","current":26.288642,"twenty":14.673898,"median":18.765235,"eighty":25.807402,"marketCap":2963597508},{"date":"2022-08-26","current":25.386069,"twenty":14.673898,"median":18.765235,"eighty":25.764749,"marketCap":2861847684},{"date":"2022-09-02","current":24.350484,"twenty":14.673898,"median":18.765235,"eighty":25.706312,"marketCap":2745103149},{"date":"2022-09-09","current":24.692512,"twenty":14.673898,"median":18.765235,"eighty":25.655304,"marketCap":2783660977},{"date":"2022-09-16","current":24.217473,"twenty":14.673898,"median":18.765235,"eighty":25.573003,"marketCap":2730108438},{"date":"2022-09-23","current":23.827942,"twenty":14.673898,"median":18.765235,"eighty":25.52154,"marketCap":2686195356},{"date":"2022-09-30","current":24.359985,"twenty":14.673898,"median":18.765235,"eighty":25.435028,"marketCap":2746174199},{"date":"2022-10-07","current":25.15805,"twenty":14.673898,"median":18.765235,"eighty":25.385744,"marketCap":2836142465},{"date":"2022-10-14","current":25.861107,"twenty":14.673898,"median":18.765235,"eighty":25.359001,"marketCap":2915400223},{"date":"2022-10-21","current":27.191216,"twenty":14.673898,"median":18.765235,"eighty":25.359001,"marketCap":3065347332},{"date":"2022-10-28","current":27.020202,"twenty":14.673898,"median":18.765235,"eighty":25.359001,"marketCap":3046068418},{"date":"2022-11-04","current":23.534301,"twenty":14.673898,"median":18.765235,"eighty":25.345826,"marketCap":2750453769},{"date":"2022-11-11","current":24.409353,"twenty":14.673898,"median":18.765235,"eighty":25.302694,"marketCap":2852721131},{"date":"2022-11-18","current":24.418564,"twenty":14.673898,"median":18.765235,"eighty":25.25389,"marketCap":2853797629},{"date":"2022-11-25","current":24.04091,"twenty":14.673898,"median":18.765235,"eighty":25.245187,"marketCap":2809661189},{"date":"2022-12-02","current":23.00927,"twenty":14.673898,"median":18.765235,"eighty":25.190124,"marketCap":2689093352},{"date":"2022-12-09","current":19.693282,"twenty":14.673898,"median":18.765235,"eighty":25.156355,"marketCap":2301553878},{"date":"2022-12-16","current":18.505053,"twenty":14.673898,"median":18.734208,"eighty":25.11858,"marketCap":2162685566},{"date":"2022-12-23","current":19.020873,"twenty":14.673898,"median":18.727537,"eighty":25.081457,"marketCap":2222969485},{"date":"2022-12-30","current":18.707697,"twenty":14.673898,"median":18.698486,"eighty":25.045958,"marketCap":2186368534},{"date":"2023-01-06","current":19.011662,"twenty":14.673898,"median":18.678417,"eighty":24.974696,"marketCap":2221892986},{"date":"2023-01-13","current":20.669656,"twenty":14.673898,"median":18.678417,"eighty":24.915538,"marketCap":2415662723},{"date":"2023-01-20","current":22.042107,"twenty":14.673898,"median":18.678417,"eighty":24.864493,"marketCap":2576061006},{"date":"2023-01-27","current":21.424965,"twenty":14.673898,"median":18.678417,"eighty":24.824329,"marketCap":2503935604},{"date":"2023-02-03","current":22.401339,"twenty":14.673898,"median":18.678417,"eighty":24.787147,"marketCap":2618044449},{"date":"2023-02-10","current":21.185477,"twenty":14.673898,"median":18.678417,"eighty":24.732601,"marketCap":2475946642},{"date":"2023-02-17","current":20.752556,"twenty":14.673898,"median":18.678417,"eighty":24.674168,"marketCap":2425351210},{"date":"2023-02-24","current":19.628805,"twenty":14.704915,"median":18.698486,"eighty":24.658704,"marketCap":2294018388},{"date":"2023-03-03","current":20.427014,"twenty":14.743485,"median":18.748075,"eighty":24.658704,"marketCap":2071666867},{"date":"2023-03-10","current":22.022874,"twenty":14.846954,"median":18.83403,"eighty":24.658704,"marketCap":2233515841},{"date":"2023-03-17","current":21.95904,"twenty":14.846954,"median":18.881519,"eighty":24.658704,"marketCap":2227041882},{"date":"2023-03-24","current":23.161255,"twenty":14.846954,"median":18.911757,"eighty":24.658704,"marketCap":2348968109},{"date":"2023-03-31","current":23.044225,"twenty":14.880165,"median":18.956878,"eighty":24.656936,"marketCap":2337099184},{"date":"2023-04-06","current":23.269603,"twenty":14.939906,"median":19.012,"eighty":24.656936,"marketCap":2359956610},{"date":"2023-04-14","current":22.558279,"twenty":14.998571,"median":19.051009,"eighty":24.658704,"marketCap":2287815518},{"date":"2023-04-21","current":22.334547,"twenty":14.998571,"median":19.104305,"eighty":24.658704,"marketCap":2265125109},{"date":"2023-04-28","current":22.344563,"twenty":14.998571,"median":19.166026,"eighty":24.658704,"marketCap":2266140860},{"date":"2023-05-05","current":25.797561,"twenty":15.006317,"median":19.199679,"eighty":24.674168,"marketCap":2437869528},{"date":"2023-05-12","current":25.70082,"twenty":15.067256,"median":19.220918,"eighty":24.732601,"marketCap":2428727517},{"date":"2023-05-19","current":25.851306,"twenty":15.164442,"median":19.305872,"eighty":24.787147,"marketCap":2442948422},{"date":"2023-05-26","current":26.356508,"twenty":15.226034,"median":19.370302,"eighty":24.824329,"marketCap":2490690034},{"date":"2023-06-02","current":24.690416,"twenty":15.273706,"median":19.394904,"eighty":24.82815,"marketCap":2333244294},{"date":"2023-06-09","current":25.840557,"twenty":15.369745,"median":19.488201,"eighty":24.87997,"marketCap":2441932643},{"date":"2023-06-16","current":24.926893,"twenty":15.394885,"median":19.593928,"eighty":24.927234,"marketCap":2355591431},{"date":"2023-06-23","current":24.023979,"twenty":15.563594,"median":19.67904,"eighty":24.927405,"marketCap":2270265997},{"date":"2023-06-30","current":23.250052,"twenty":15.628233,"median":19.743196,"eighty":24.927575,"marketCap":2197129912},{"date":"2023-07-07","current":23.615517,"twenty":15.686181,"median":19.772513,"eighty":24.927575,"marketCap":2231666397},{"date":"2023-07-14","current":24.314201,"twenty":15.761523,"median":19.849055,"eighty":24.927746,"marketCap":2297692030},{"date":"2023-07-21","current":25.077379,"twenty":15.821796,"median":19.960736,"eighty":24.935276,"marketCap":2369812337},{"date":"2023-07-28","current":26.904706,"twenty":15.876709,"median":20.074148,"eighty":25.002136,"marketCap":2542494761},{"date":"2023-08-04","current":33.858501,"twenty":15.929368,"median":20.130809,"eighty":25.06021,"marketCap":3203555971},{"date":"2023-08-11","current":33.273239,"twenty":15.97248,"median":20.230235,"eighty":25.077379,"marketCap":3148180804},{"date":"2023-08-18","current":33.067314,"twenty":16.047822,"median":20.286868,"eighty":25.09781,"marketCap":3128696949},{"date":"2023-08-25","current":34.432925,"twenty":16.153301,"median":20.335787,"eighty":25.131471,"marketCap":3257905672},{"date":"2023-09-01","current":35.473392,"twenty":16.199879,"median":20.360084,"eighty":25.165508,"marketCap":3356350414},{"date":"2023-09-08","current":35.928595,"twenty":16.288916,"median":20.424644,"eighty":25.202732,"marketCap":3399419988},{"date":"2023-09-15","current":36.633078,"twenty":16.372908,"median":20.485854,"eighty":25.247633,"marketCap":3466075282},{"date":"2023-09-22","current":34.606336,"twenty":16.402788,"median":20.528058,"eighty":25.271098,"marketCap":3274313129},{"date":"2023-09-29","current":35.755184,"twenty":16.454668,"median":20.647713,"eighty":25.318027,"marketCap":3383012531},{"date":"2023-10-06","current":28.710362,"twenty":16.484805,"median":20.739765,"eighty":25.352329,"marketCap":2716459592},{"date":"2023-10-13","current":29.935077,"twenty":16.545079,"median":20.805107,"eighty":25.396593,"marketCap":2832337257},{"date":"2023-10-20","current":30.346928,"twenty":16.62042,"median":20.91148,"eighty":25.46924,"marketCap":2871304968},{"date":"2023-10-27","current":29.870048,"twenty":16.635578,"median":20.971474,"eighty":25.500078,"marketCap":2826184461},{"date":"2023-11-03","current":28.378566,"twenty":16.744505,"median":21.039532,"eighty":25.568245,"marketCap":2593403665},{"date":"2023-11-10","current":28.097921,"twenty":16.816673,"median":21.093333,"eighty":25.60843,"marketCap":2567756602},{"date":"2023-11-17","current":28.323516,"twenty":16.948321,"median":21.176265,"eighty":25.655139,"marketCap":2588372874},{"date":"2023-11-24","current":28.571672,"twenty":16.9786,"median":21.207187,"eighty":25.701265,"marketCap":2611050772},{"date":"2023-12-01","current":28.729588,"twenty":17.023968,"median":21.222783,"eighty":25.744003,"marketCap":2625482162},{"date":"2023-12-08","current":30.15084,"twenty":17.075645,"median":21.281808,"eighty":25.795392,"marketCap":2755364672},{"date":"2023-12-15","current":33.647571,"twenty":17.145357,"median":21.387263,"eighty":25.809981,"marketCap":3074916879},{"date":"2023-12-22","current":35.711769,"twenty":17.182275,"median":21.514351,"eighty":25.859066,"marketCap":3263555762},{"date":"2023-12-29","current":37.087902,"twenty":17.245845,"median":21.57635,"eighty":25.875763,"marketCap":3389315018},{"date":"2024-01-05","current":28.582951,"twenty":17.249581,"median":21.617351,"eighty":25.902621,"marketCap":2612081586},{"date":"2024-01-12","current":26.451074,"twenty":17.300075,"median":21.662782,"eighty":26.071548,"marketCap":2417257821},{"date":"2024-01-19","current":27.906165,"twenty":17.358343,"median":21.792961,"eighty":26.115814,"marketCap":2550232772},{"date":"2024-01-26","current":25.898365,"twenty":17.391973,"median":21.940702,"eighty":26.170789,"marketCap":2366747956},{"date":"2024-02-02","current":24.398155,"twenty":17.425443,"median":22.062266,"eighty":26.170789,"marketCap":2229649751},{"date":"2024-02-09","current":25.368215,"twenty":17.524077,"median":22.147709,"eighty":26.170789,"marketCap":2318299718},{"date":"2024-02-16","current":23.855618,"twenty":17.589266,"median":22.21893,"eighty":26.191114,"marketCap":2532035310},{"date":"2024-02-23","current":22.42194,"twenty":17.626358,"median":22.234584,"eighty":26.191114,"marketCap":2379864750},{"date":"2024-03-01","current":22.919339,"twenty":17.633519,"median":22.273273,"eighty":26.186954,"marketCap":2432658618},{"date":"2024-03-08","current":22.802304,"twenty":17.633519,"median":22.340405,"eighty":26.186954,"marketCap":2420236531},{"date":"2024-03-15","current":23.085138,"twenty":17.633519,"median":22.41652,"eighty":26.186954,"marketCap":2450256573},{"date":"2024-03-22","current":24.138453,"twenty":17.633519,"median":22.460952,"eighty":26.186954,"marketCap":2562055353},{"date":"2024-03-28","current":24.694368,"twenty":17.690591,"median":22.494795,"eighty":26.186954,"marketCap":2621060264},{"date":"2024-04-05","current":24.43104,"twenty":17.751499,"median":22.557044,"eighty":26.191114,"marketCap":2593110569},{"date":"2024-04-12","current":23.303197,"twenty":17.751499,"median":22.576228,"eighty":26.191114,"marketCap":2473401294},{"date":"2024-04-19","current":22.168364,"twenty":17.751499,"median":22.605072,"eighty":26.191114,"marketCap":2352950181},{"date":"2024-04-26","current":21.728128,"twenty":17.75667,"median":22.602899,"eighty":26.186954,"marketCap":2306223456},{"date":"2024-05-03","current":22.106275,"twenty":17.75667,"median":22.608023,"eighty":26.186954,"marketCap":2609048925},{"date":"2024-05-10","current":23.464761,"twenty":17.774039,"median":22.609769,"eighty":26.186954,"marketCap":2769381540},{"date":"2024-05-17","current":24.293967,"twenty":17.84352,"median":22.678242,"eighty":26.186954,"marketCap":2867246903},{"date":"2024-05-24","current":24.558607,"twenty":17.897853,"median":22.753585,"eighty":26.186954,"marketCap":2898480529},{"date":"2024-05-31","current":27.531399,"twenty":17.929134,"median":22.805275,"eighty":26.264877,"marketCap":3249338266},{"date":"2024-06-07","current":30.415976,"twenty":17.97088,"median":22.828928,"eighty":26.281877,"marketCap":3589784794},{"date":"2024-06-14","current":27.796039,"twenty":18.005093,"median":22.893398,"eighty":26.32196,"marketCap":3280571892},{"date":"2024-06-21","current":25.934736,"twenty":18.025346,"median":22.970196,"eighty":26.326142,"marketCap":3060895387},{"date":"2024-06-28","current":28.281212,"twenty":18.058813,"median":23.010789,"eighty":26.361392,"marketCap":3337833541},{"date":"2024-07-05","current":26.905084,"twenty":18.08407,"median":23.045023,"eighty":26.401346,"marketCap":3175418684},{"date":"2024-07-12","current":27.496113,"twenty":18.125253,"median":23.112931,"eighty":26.435971,"marketCap":3245173782},{"date":"2024-07-15","current":27.787218,"twenty":18.151583,"median":23.125276,"eighty":26.439168,"marketCap":3279530772},{"date":"2024-08-02","current":31.468089,"twenty":18.227878,"median":23.207056,"eighty":26.472425,"marketCap":3964444273},{"date":"2024-08-09","current":28.258245,"twenty":18.289588,"median":23.250052,"eighty":26.573962,"marketCap":3560058418},{"date":"2024-08-16","current":28.979837,"twenty":18.299654,"median":23.308355,"eighty":26.638271,"marketCap":3650966866},{"date":"2024-08-23","current":28.432422,"twenty":18.299654,"median":23.412836,"eighty":26.737384,"marketCap":3582001837},{"date":"2024-08-30","current":29.145721,"twenty":18.420312,"median":23.48289,"eighty":26.875577,"marketCap":3671865360},{"date":"2024-09-06","current":28.283127,"twenty":18.479546,"median":23.50276,"eighty":26.907206,"marketCap":3563193192},{"date":"2024-09-13","current":29.618489,"twenty":18.489602,"median":23.553278,"eighty":26.969813,"marketCap":3731426067},{"date":"2024-09-20","current":33.939752,"twenty":18.489602,"median":23.628594,"eighty":27.012802,"marketCap":4275831831},{"date":"2024-09-27","current":35.897177,"twenty":18.489602,"median":23.704432,"eighty":27.065252,"marketCap":4522434058},{"date":"2024-10-04","current":37.356951,"twenty":18.489602,"median":23.766003,"eighty":27.198317,"marketCap":4706340803},{"date":"2024-10-11","current":37.531129,"twenty":18.489602,"median":23.79825,"eighty":27.269122,"marketCap":4728284222},{"date":"2024-10-18","current":39.12361,"twenty":18.489602,"median":23.827222,"eighty":27.390639,"marketCap":4928909762},{"date":"2024-10-25","current":39.181669,"twenty":18.489602,"median":23.839773,"eighty":27.531768,"marketCap":4936224235},{"date":"2024-10-31","current":34.548872,"twenty":18.489602,"median":23.855618,"eighty":27.607335,"marketCap":4899651871},{"date":"2024-11-08","current":40.116839,"twenty":18.488035,"median":23.944067,"eighty":27.690634,"marketCap":5689289939},{"date":"2024-11-15","current":40.478851,"twenty":18.488035,"median":24.018628,"eighty":27.792827,"marketCap":5740629756},{"date":"2024-11-22","current":41.313695,"twenty":18.501556,"median":24.046375,"eighty":27.825976,"marketCap":5859025661},{"date":"2024-11-29","current":42.613983,"twenty":18.57617,"median":24.098183,"eighty":27.94226,"marketCap":6043429902},{"date":"2024-12-06","current":43.899495,"twenty":18.605886,"median":24.135934,"eighty":28.081714,"marketCap":6225738640},{"date":"2024-12-13","current":41.612909,"twenty":18.704013,"median":24.157567,"eighty":28.205158,"marketCap":5901459591},{"date":"2024-12-20","current":37.789619,"twenty":18.861587,"median":24.179738,"eighty":28.267432,"marketCap":5359248257},{"date":"2024-12-27","current":39.621843,"twenty":18.901855,"median":24.222326,"eighty":28.295017,"marketCap":5619090597},{"date":"2025-01-03","current":36.917836,"twenty":18.962014,"median":24.246775,"eighty":28.334601,"marketCap":5235613595},{"date":"2025-01-10","current":38.188571,"twenty":19.031446,"median":24.276325,"eighty":28.377038,"marketCap":5415826831},{"date":"2025-01-17","current":40.220271,"twenty":19.099543,"median":24.296939,"eighty":28.43093,"marketCap":5703958458},{"date":"2025-01-24","current":46.019851,"twenty":19.160732,"median":24.33572,"eighty":28.461514,"marketCap":6526443283},{"date":"2025-01-31","current":51.642119,"twenty":19.203927,"median":24.359985,"eighty":28.529757,"marketCap":7323782076},{"date":"2025-02-07","current":50.267951,"twenty":19.239158,"median":24.395104,"eighty":28.578439,"marketCap":7128900321},{"date":"2025-02-14","current":54.383067,"twenty":19.337603,"median":24.413752,"eighty":28.61904,"marketCap":7712497834},{"date":"2025-02-21","current":48.088491,"twenty":19.396463,"median":24.43104,"eighty":28.65241,"marketCap":6819813667},{"date":"2025-02-28","current":44.716558,"twenty":19.542449,"median":24.466366,"eighty":28.709029,"marketCap":6314380405},{"date":"2025-03-07","current":40.56991,"twenty":19.695185,"median":24.537351,"eighty":28.774142,"marketCap":5728836357},{"date":"2025-03-14","current":40.980839,"twenty":19.748215,"median":24.572457,"eighty":28.848313,"marketCap":5786863245},{"date":"2025-03-21","current":43.028013,"twenty":19.828981,"median":24.656668,"eighty":28.895923,"marketCap":6075942648},{"date":"2025-03-28","current":42.348112,"twenty":20.044795,"median":24.686713,"eighty":29.033234,"marketCap":5979934525},{"date":"2025-04-04","current":59.300805,"twenty":20.122482,"median":24.719586,"eighty":29.225898,"marketCap":8373807397},{"date":"2025-04-11","current":50.604051,"twenty":20.229693,"median":24.759018,"eighty":29.315721,"marketCap":7145747449},{"date":"2025-04-17","current":48.265491,"twenty":20.286086,"median":24.779141,"eighty":29.454515,"marketCap":6815521707},{"date":"2025-04-25","current":53.637455,"twenty":20.348792,"median":24.821915,"eighty":29.620251,"marketCap":7574091383}],"updateTime":1745832667544}}}